Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01329-18. Print 2018 Dec 1.
Replication of vaccinia virus in human cells depends on the viral C7 or K1 protein. A previous human genome-wide short interfering RNA (siRNA) screen with a C7/K1 double deletion mutant revealed SAMD9 as a principal host range restriction factor along with additional candidates, including WDR6 and FTSJ1. To compare their abilities to restrict replication, the cellular genes were individually inactivated by CRISPR/Cas9 mutagenesis. The C7/K1 deletion mutant exhibited enhanced replication in each knockout (KO) cell line but reached wild-type levels only in SAMD9 KO cells. SAMD9 was not depleted in either WDR6 or FTSJ1 KO cells, suggesting less efficient alternative rescue mechanisms. Using the SAMD9 KO cells as controls, we verified a specific block in host and viral intermediate and late protein synthesis in HeLa cells and demonstrated that the inhibition could be triggered by events preceding viral DNA replication. Inhibition of cap-dependent and -independent protein synthesis occurred primarily at the translational level, as supported by DNA and mRNA transfection experiments. Concurrent with collapse of polyribosomes, viral mRNA was predominantly in 80S and lighter ribonucleoprotein fractions. We confirmed the accumulation of cytoplasmic granules in HeLa cells infected with the C7/K1 deletion mutant and further showed that viral mRNA was sequestered with SAMD9. RNA granules were still detected in G3BP KO U2OS cells, which remained nonpermissive for the C7/K1 deletion mutant. Inhibition of cap-dependent and internal ribosome entry site-mediated translation, sequestration of viral mRNA, and failure of PKR, RNase L, or G3BP KO cells to restore protein synthesis support an unusual mechanism of host restriction. A dynamic relationship exists between viruses and their hosts in which each ostensibly attempts to exploit the other's vulnerabilities. A window is opened into the established condition, which evolved over millennia, if loss-of-function mutations occur in either the virus or host. Thus, the inability of viral host range mutants to replicate in specific cells can be overcome by identifying and inactivating the opposing cellular gene. Here, we investigated a C7/K1 host range mutant of vaccinia virus in which the cellular gene SAMD9 serves as the principal host restriction factor. Host restriction was triggered early in infection and manifested as a block in translation of viral mRNAs. Features of the block include inhibition of cap-dependent and internal ribosome entry site-mediated translation, sequestration of viral RNA, and inability to overcome the inhibition by inactivation of protein kinase R, ribonuclease L, or G3 binding proteins, suggesting a novel mechanism of host restriction.
痘苗病毒在人类细胞中的复制依赖于病毒的 C7 或 K1 蛋白。之前,使用具有 C7/K1 双重缺失突变的人类全基因组短干扰 RNA(siRNA)筛选发现 SAMD9 是主要的宿主范围限制因子,同时还发现了其他候选因子,包括 WDR6 和 FTSJ1。为了比较它们限制复制的能力,我们通过 CRISPR/Cas9 诱变使细胞基因逐个失活。C7/K1 缺失突变体在每种敲除(KO)细胞系中的复制能力增强,但仅在 SAMD9 KO 细胞中达到野生型水平。在 WDR6 或 FTSJ1 KO 细胞中均未耗尽 SAMD9,表明存在效率较低的替代挽救机制。我们使用 SAMD9 KO 细胞作为对照,在 HeLa 细胞中验证了宿主和病毒中间和晚期蛋白合成的特定阻断,并表明这种抑制作用可以通过病毒 DNA 复制之前的事件触发。在 DNA 和 mRNA 转染实验的支持下,发现翻译起始因子依赖性和非依赖性蛋白合成的抑制主要发生在翻译水平上。伴随着多核糖体的崩溃,病毒 mRNA 主要存在于 80S 和更轻的核糖核蛋白部分。我们在感染 C7/K1 缺失突变体的 HeLa 细胞中证实了细胞质颗粒的积累,并进一步表明 SAMD9 可将病毒 mRNA 隔离。在 G3BP KO U2OS 细胞中仍检测到 RNA 颗粒,该细胞对 C7/K1 缺失突变体仍不允许。翻译起始因子依赖性和内部核糖体进入位点介导的翻译抑制、病毒 mRNA 的隔离以及 PKR、RNase L 或 G3BP KO 细胞无法恢复蛋白合成均支持一种不寻常的宿主限制机制。病毒和宿主之间存在着一种动态关系,在这种关系中,每个病毒都试图利用对方的弱点。如果病毒或宿主发生功能丧失突变,就会打开一个经过数千年建立起来的既定条件。因此,如果识别出并失活相反的细胞基因,病毒宿主范围突变体就可以在特定细胞中复制。在这里,我们研究了痘苗病毒的 C7/K1 宿主范围突变体,其中细胞基因 SAMD9 作为主要的宿主限制因子。宿主限制作用在感染早期被触发,并表现为病毒 mRNA 翻译的阻断。该阻断的特征包括翻译起始因子依赖性和内部核糖体进入位点介导的翻译抑制、病毒 RNA 的隔离以及无法通过失活蛋白激酶 R、核糖核酸酶 L 或 G3 结合蛋白来克服抑制作用,这表明了一种新的宿主限制机制。